KPW
SRNE

Kore Private Wealth’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Kore Private Wealth’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-37,302
Closed -$69K – 1297
2020
Q1 		$69K Sell
37,302
-40,212
-52% -$116K 0.02% 361
2019
Q4 		$262K Hold
77,514
– – 0.05% 211
2019
Q3 		$157K Hold
77,514
– – 0.04% 220
2019
Q2 		$207K Buy
77,514
+56,028
+261% +$202K 0.05% 210
2019
Q1 		$102K Buy
21,486
+9,776
+83% +$25.6K 0.02% 285
2018
Q4 		$28K Buy
+11,710
New +$38.2K 0.01% 451

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Kore Private Wealth's SRNE Position: Q2 2020 in Review

Kore Private Wealth sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2020, closing a stake of 37,302 shares — an estimated $69K sold.

Kore Private Wealth first reported a position in SRNE in Q4 2018 and held it in 6 quarters. The position peaked at $262K in Q4 2019. 186 funds tracked by Wall St. Rank hold SRNE as of Q2 2020.

  • Kore Private Wealth reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Kore Private Wealth sold 37,302 Sorrento Therapeutics, Inc. shares in Q2 2020, an estimated $69K.
  • Kore Private Wealth first reported a position in Sorrento Therapeutics, Inc. in Q4 2018 and held it in 6 quarters.
  • Kore Private Wealth's Sorrento Therapeutics, Inc. position peaked at $262K in Q4 2019.
  • 186 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2020.

Based on Kore Private Wealth's 13F filing for Q2 2020, filed 14 Aug 2020.